Following the company’s second quarter results, Stifel analyst Justin Keywood remains bullish on WELL Health Technologies (WELL Health Technologies Stock Quote, Chart, News, Analysts, Financials TSX:WELL). On August 14, WELL posted its Q2, 2024 results. The company reported Adjusted EBITDA of $30.9-million on revenue of $243.1-million, a topline that was up 42% over the same […]
DR stock wins price target raise at LeedeFollowing the company’s second quarter results, Leede Jones Gable analyst Douglas Loe has raised his price target on Medical Facilities Corp. (Medical Facilities Corp. Stock Quote, Chart, News, Analysts, Financials TSX:DR). On August 6, DR reported its Q2, 2024 results. The company posted EBITDA of $23.8-million on revenue of US $107.2-million. “In addition to favourable […]